BRIEF published on 07/20/2026 at 19:10, 1 month 22 days ago New Management at Dubuit Inks Governance Appointment Industry DUBUIT Inks Jérôme Bracichowicz
BRIEF published on 07/20/2026 at 19:10, 1 month 22 days ago Nouvelle Direction chez Encres Dubuit Gouvernance Industrie Nomination Encres Dubuit Jérôme Bracichowicz
REGULATED PRESS RELEASE published on 07/20/2026 at 19:05, 1 month 22 days ago EVOLUTION DE LA GOUVERNANCE – NOMINATION D’UN NOUVEAU DIRECTEUR GENERAL Encres DUBUIT annonce la nomination d'un nouveau directeur général, Jérôme Bracichowicz, pour assurer la transition stratégique et opérationnelle de l'entreprise Conseil D'administration Nomination Directeur Général Transition Stratégique Encres Dubuit
BRIEF published on 06/19/2026 at 19:10, 2 months 22 days ago Change in governance at DUBUIT Inks Board Of Directors Governance Change Corporate Strategy DUBUIT Inks Jean-Louis Dubuit
BRIEF published on 06/19/2026 at 19:10, 2 months 22 days ago Changement de gouvernance chez Encres DUBUIT Stratégie D'entreprise Conseil D'administration Changement De Gouvernance Encres Dubuit Jean-Louis Dubuit
REGULATED PRESS RELEASE published on 06/19/2026 at 19:05, 2 months 22 days ago CP - Changement de gouvernance ENCRES DUBUIT annonce la mise en œuvre du changement de gouvernance avec l'adoption d'un Conseil d'administration et la nomination des administrateurs Conseil D'administration Nomination Changement De Gouvernance Administrateurs Encres Dubuit
BRIEF published on 05/29/2026 at 21:47, 3 months 13 days ago DUBUIT INKS: Detailed Share Buyback Program Share Capital Share Buyback AMF General Assembly DUBUIT Inks
BRIEF published on 05/29/2026 at 21:47, 3 months 13 days ago ENCRES DUBUIT : Programme de Rachat d'Actions Détaillé Rachat D'actions Capital Social AMF Assemblé Générale Encres Dubuit
REGULATED PRESS RELEASE published on 05/29/2026 at 21:42, 3 months 13 days ago Descriptif du programme de rachat d'actions Descritif du programme de rachat d'actions d'Encres Dubuit, approbation de l'AG du 26/06/2025, max 10% du capital, prix max 8€/action, montant max programme 2 512 800 euros, durée 18 mois Capital Programme Rachat Actions AG Encres Dubuit
BRIEF published on 05/22/2026 at 19:40, 3 months 20 days ago Encres DUBUIT : Evolution de Gouvernance et Nomination d'un Président par Intérim Gouvernance Assemblée Générale Changement Encres Dubuit Président Intérim
Published on 09/12/2026 at 02:35, 11 hours 16 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 14 hours 51 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 15 hours 46 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 16 hours 26 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 20 hours 51 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 07:30, 6 hours 20 minutes ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 15 hours 36 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 15 hours 40 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 18 hours 6 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 19 hours 35 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 1 day 6 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 6 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 18 hours ago Availability of the 2026 Interim Financial Report
